Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)-resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Engels |
| Gepubliceerd in: |
2009
|
| Online toegang: | https://doi.org/10.1002/hep.23145 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.23145 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|